Daiichi Sankyo pumping $135m into antibody-drug conjugate production
Daiichi Sankyo will plough ¥15bn ($135m) into three Japanese manufacturing facilities to support its antibody-drug conjugate pipeline.
Archives for April 27, 2017
PharmaCell to make autologous cell therapies for Lion Biotech
Dutch contract manufacturer PharmaCell B.V has signed a three-year Manufacturing Services Agreement to make cancer cell therapies for Lion Biotechnologies.
GSK to ship malaria vaccine for African pilot programme
GSK says maintaining an unbroken cold chain will be critical as it prepares to rollout malaria vaccine pilot programme.
DISPATCHES FROM BPI EUROPE 2017
CHO stopper? Biogen looks to alternative cell lines for future of bioproduction
The Chinese hamster ovary (CHO) cell line is not the future for biomanufacturing says Biogen, which will publish results from a study of alternative hosts later this year.